Health

AI ยท 251 companies ยท 438 deals tracked
251 Companies
438 Deals Tracked
AI Sector

Health Companies

Allos AI Allos AI ๐ŸŒ Signacor Therapeutics Signacor Therapeutics ๐Ÿ‡ฌ๐Ÿ‡ง Smile Genius Smile Genius ๐Ÿ‡ฎ๐Ÿ‡ช Nitra Nitra ๐ŸŒ Eolas Medical Eolas Medical ๐Ÿ‡ฌ๐Ÿ‡ง Recare Recare ๐Ÿ‡ฉ๐Ÿ‡ช FICUS Health FICUS Health ๐Ÿ‡ฉ๐Ÿ‡ช Emerald ๐Ÿ‡ฌ๐Ÿ‡ง Holo Holo ๐Ÿ‡ช๐Ÿ‡ธ Captain T Cell Captain T Cell ๐ŸŒ

Latest Deals in Health

$3.5M
Outpost Bio, a London-based developer of AI-driven microbiology models, raised $3.5 million in pre-seed funding. The round was co-led by Merantix Capital and Seedcamp, with participation from OpenSeed VC and Defined, along with family offices and angel investors. The funds will be used to advance the company's experimental and modeling infrastructure.
Investors: Merantix Capital, Seedcamp, OpenSeed VC, Defined
Health Mar 2, 2026
$3.5M
Outpost Bio has raised $3.5 million in a pre-seed funding round co-led by Merantix Capital and Seedcamp, with additional participation from OpenSeed VC and other investors. The company focuses on human microbiology, addressing the challenge of translating complex biological interactions into actionable insights for R&D. Its lab-in-the-loop platform integrates automated experimentation with machine learning to generate proprietary datasets, aiding pharmaceutical and consumer health companies in product development and regulatory compliance.
Investors: Merantix Capital, Seedcamp, OpenSeed VC
Health Mar 2, 2026
$3.5M
Outpost Bio, a company focused on decoding human microbiology, has raised $3.5 million in a pre-seed round co-led by Merantix Capital and Seedcamp, with participation from OpenSeed VC and others. The company addresses the challenge of translating complex biological interactions into actionable insights, using a lab-in-the-loop platform that combines automated experimentation and machine learning. This funding will enhance their experimental and modeling platforms, aiding pharmaceutical and consumer health product development.
Investors: Merantix Capital, Seedcamp, OpenSeed VC
Health Mar 2, 2026
Heidi, a Melbourne-based healthcare AI platform, has launched Heidi Evidence and acquired UK-based clinical AI company Automedica. This expansion aims to enhance real-time clinical reasoning and communications, alongside the introduction of Heidi Comms, an AI tool to assist healthcare teams with patient management tasks.
Health Mar 1, 2026
Nexus Precision Health: Acquisition Of Leal Health To Accelerate Precision Medicine At Scale
Health Feb 28, 2026
$0.0002M
Emerging Technology Centers (ETC) Baltimore has invested $200,000 in Junebrain's Series Seed+ funding round to support the development of its AI-powered retinal imaging platform. This investment aims to accelerate Junebrain's path toward FDA clearance and expand access to advanced diagnostics in Baltimore communities. Founded in 2017, Junebrain's flagship product, the neuro-i ss-oct, enables high-resolution imaging for eye and brain diseases, addressing barriers to specialty services in underserved areas.
Investors: Emerging Technology Centers
Health Feb 27, 2026
$0.0002M
Emerging Technology Centers (ETC) Baltimore has invested $200,000 in Junebrain's Series Seed+ funding round to support the development of its AI-powered retinal imaging platform. This investment aims to accelerate Junebrain's path toward FDA clearance and expand access to advanced diagnostics in Baltimore communities. Founded in 2017, Junebrain's flagship product, the neuro-i ss-oct, enables high-resolution imaging for eye and brain diseases, addressing barriers to specialty services in underserved areas.
Investors: Emerging Technology Centers
Health Feb 27, 2026
$15M
Third Way Health (TWH), an AI-enabled services partner for healthcare organizations, has raised an oversubscribed $15 million in a Series A funding round led by Health Velocity Capital, with Kristin Torres Mowat as the lead investor. This funding increases the company's total to $22.5 million, aimed at enhancing product investment and operational scale.
Investors: Health Velocity Capital, Kristin Torres Mowat
Health Feb 26, 2026
$13M
Braincheck, a digital platform for cognitive assessment, has raised $13 million in Series A financing led by Next Coast Ventures, with participation from S3 Ventures and UPMC Enterprises. The funding will enhance Braincheck's cognitive care infrastructure, enabling deeper integration and scalable deployment in healthcare settings. The platform aims to improve early identification of cognitive impairment and support structured follow-up care, addressing the growing need for cognitive health solutions as populations age.
Investors: Next Coast Ventures, S3 Ventures, UPMC Enterprises
Health Feb 26, 2026
$15M
Third Way Health, a Los Angeles-based AI-enabled services company for healthcare organizations, raised $15 million in Series A funding led by Health Velocity Capital, with partner Kristin Torres Mowat. This funding round increased the total amount raised to $22.5 million, which the company plans to use to accelerate customer growth and expand its operational footprint.
Investors: Health Velocity Capital
Health Feb 26, 2026
$11.88M
Oska Health has secured an โ‚ฌ11 million seed round led by Capricorn Partners and Swisshealth Ventures to address chronic care in Europe. The company, founded in 2022 in Frankfurt am Main, combines health coaches with technology to support patients with multiple chronic conditions. With partnerships established with over 20 health insurance funds in Germany, Oska aims to reduce hospitalizations and improve health literacy, addressing a significant gap in chronic disease management.
Investors: Capricorn Partners, Swisshealth Ventures
Health Feb 26, 2026
$11.88M
Oska Health, a hybrid care provider, has secured โ‚ฌ11 million in seed funding to enhance its continuous care model for high-risk patients with chronic conditions. The funding round was led by Capricorn Partners and SwissHealth Ventures, addressing the issue of patients struggling to maintain healthy behaviors between doctor visits. Oska Health combines AI with personal health coaching to support multimorbid patients, aiming to improve health literacy and reduce hospitalizations. The fresh funding will accelerate the expansion of its AI-driven care infrastructure.
Investors: Capricorn Partners, SwissHealth Ventures
Health Feb 26, 2026
$11.88M
Oska Health, a hybrid care provider, has raised โ‚ฌ11 million in seed funding to enhance its continuous care model for high-risk, chronically ill patients. The funding round was led by Capricorn Partners and SwissHealth Ventures, with participation from several investors. Oska Health addresses significant gaps in chronic disease management by offering personalized digital support between medical appointments, combining human coaching with AI-enabled care delivery. The new capital will accelerate the expansion of its AI-powered care infrastructure.
Investors: Capricorn Partners, SwissHealth Ventures
Health Feb 26, 2026
$7.5M
Centauri Therapeutics, a UK-based immunotherapy company, has raised ยฃ6 million in a Series A extension led by the AMR Action Fund, bringing total Series A funding to ยฃ30 million. The funds will be used to complete Phase I clinical studies for ctx-187, a broad-spectrum antimicrobial targeting multidrug-resistant gram-negative bacteria, and to prepare for Phase II trials. The AMR Action Fund aims to support the advancement of ctx-187 through key safety data generation.
Investors: AMR Action Fund
Health Feb 26, 2026
$25.4M
Brainomix, a leader in AI-powered imaging tools for stroke and lung fibrosis, has secured an additional ยฃ4.8 million (approximately $6.5 million) in its Series C financing, bringing the total to ยฃ18.8 million (around $25.4 million). The funding, led by Parkwalk Advisors and Hostplus, along with new investor Modi Ventures, will enhance the deployment of its AI platforms, Brainomix 360 Stroke and e-lung, across U.S. hospitals, improving patient care in stroke and lung disease management.
Investors: Parkwalk Advisors, Hostplus, Modi Ventures
Health Feb 25, 2026
Clee Medical, a Swiss neurotechnology startup, has secured seed financing led by High-Tech Grรผnderfonds, with participation from Zรผrcher Kantonalbank, Kickfund, Fongit, and Venture Kick. The company is developing ultra-high-resolution, real-time imaging technology to enhance precision in neurosurgery, addressing challenges like changes in brain anatomy and limited visibility during procedures. The funding will support the expansion of development and clinical programs, including preparations for a first-in-human clinical study.
Investors: High-Tech Grรผnderfonds, Zรผrcher Kantonalbank, Kickfund, Fongit, Venture Kick
Health Feb 25, 2026
$25M
Turbine, a virtual biology company specializing in AI-powered drug discovery, has raised $25 million in a Series B financing round led by Interactive Venture Partners, with participation from Beiersdorf AG and existing investors including MSD Global Health Innovation, Accel, and Mercia. The funding will help Turbine expand its platform into immunology, marking a shift beyond oncology.
Investors: Interactive Venture Partners, Beiersdorf AG, MSD Global Health Innovation, Accel, Mercia
Health Feb 24, 2026
Carvolix, co-founded by Dr. Philippe Pouletty, aims to address the treatment gap in cardiovascular care, where only 17% of patients are eligible for aortic valve replacement and just 5% of stroke victims receive emergency treatment. The company merges cardiovascular implants with AI-driven software and mini-robotics to enhance treatment accessibility. Key investors include Truffle Capital, and the venture is part of a deliberate consolidation strategy to create a unified platform for advanced medical interventions.
Investors: Truffle Capital
Health Feb 24, 2026
$25M
Turbine, a virtual biology company, has secured $25 million in a Series B financing round led by Interactive Venture Partners, with participation from Beiersdorf AG and existing investors. The funding will enable Turbine to expand its virtual cell platform and develop new immunology-focused collaborations with a top 10 pharma company. This investment aims to enhance drug discovery by virtualizing biological experiments, allowing researchers to explore complex drug combinations efficiently.
Investors: Interactive Venture Partners, Beiersdorf AG
Health Feb 24, 2026
$25.4M
brainomix, an AI medical imaging company focused on stroke and lung fibrosis, has secured a ยฃ4.8 million extension to its Series C financing, raising the total to ยฃ18.8 million (approximately $25.4 million). This funding will support the company's expansion of AI imaging platforms in the U.S.
Health Feb 24, 2026